Aurobindo Pharma Limited (BOM:524804)

Despegar.com Revenue

Aurobindo Pharma had revenue of 78.68B INR in the quarter ending June 30, 2025, with 3.98% growth. This brings the company's revenue in the last twelve months to 320.25B, up 7.76% year-over-year. In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B with 9.39% growth.

• Revenue (ttm): 320.25B
• Revenue Growth: +7.76%
• P/S Ratio: 1.89
• Revenue / Employee: 12.31M
• Employees: 26,015
• Market Cap: 605.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	317.24B	27.22B	9.39%
Mar 31, 2024	290.02B	41.46B	16.68%
Mar 31, 2023	248.55B	14.00B	5.97%
Mar 31, 2022	234.55B	-13.19B	-5.32%
Mar 31, 2021	247.75B	16.76B	7.26%